Artivion | CRY - Bruttoergebnis Vom Umsatz





Bruttoergebnis Vom Umsatz Veränderung Datum
Abbott USD 6.65B 787M 2026-06
Accuray USD 41.89M 7.42M 2024-12
AngioDynamics USD 44.78M 2.93M 2025-09
Artivion USD 73.14M 1.25M 2025-12
AtriCure USD 109.31M 3.97M 2026-03
Baxter International USD 891M 314M 2026-03
Becton, Dickinson and Co. USD 2.15B 257M 2026-03
Boston Scientific USD 3.82B 210M 2026-06
Edwards Lifesciences USD 1.35B 62.6M 2026-06
Inogen USD 41.34M 1.39M 2024-09
Integra LifeSciences USD 215.97M 2.77M 2026-06
J&J USD 18.55B 1.31B 2026-06
Mesa Laboratories USD 39.75M 4.3M 2024-12
Orthofix International USD 153.28M 4.76M 2025-12
Pfizer USD 11.04B 1.24B 2026-03
ResMed USD 890.98M 12.26M 2026-03
Stryker USD 3.81B 675M 2026-03
Tandem Diabetes Care USD 167.46M 33.17M 2025-12
Teleflex USD 307.43M 21K 2026-03
Terumo JPY 149.02B 4.17B 2026-03
Trinity Biotech USD 6.47M 1.59M 2025-09